Diagnostic instrumentation and medical device provider Alcor Scientific has partnered with strategic healthcare investor Water Street Healthcare Partners, who will help invest in the company’s expansion.
The company has also appointed diagnostics leader Jim Post as its chief executive officer to spearhead its next phase of innovation and growth. Most recently, Post led the growth and successful sale of Thermo Fisher Scientific’s anatomic pathology business to PHC Holdings Corporation.
“Innovation is the cornerstone of Alcor. Our family founded and grew this company by conceiving and developing new medical technologies that meaningfully improve patient care,” says Carlo Ruggeri, founder, Alcor. “I’m very pleased to have found in Water Street a strategic partner that values our legacy and will help us build on it. Water Street’s diagnostics and medical products expertise combined with the experience of our new CEO, Jim Post, will help us not only build – but accelerate – Alcor’s next phase of innovation and growth.”
Alcor Scientific says it plans to leverage Water Street Healthcare Partners’ investment to achieve its goals for accelerating the development of new technologies, expanding its product portfolio and bolstering its global reach. Founded in 2010, Alcor offers a fully automated solution for Erythrocyte Sedimentation Rate (ESR) testing, which measures inflammation for a range of clinical purposes, including diagnosing and monitoring autoimmune diseases, cancer and infections.
“Alcor stands out for its exceptionally high customer satisfaction and retention ratings. Health care providers greatly value Alcor’s ESR testing system, saying it helps save time and labor costs to improve their overall workflow,” says Scott Garrett, operating partner, Water Street. “Together with Carlo and the leadership team, we will build on this strong foundation through organic investments and acquisitions of complementary products and technologies to extend its product portfolio and global reach.”
Most recently, Post led the growth and successful sale of Thermo Fisher Scientific’s anatomic pathology business to PHC Holdings Corporation.
For more information visit www.alcorscientific.com
